logo
Share SHARE
FONT-SIZE Plus   Neg

WSJ: Coldwater Creek Prepares To File For Bankruptcy

Coldwater Creek Inc. (CWTR) is preparing to file for bankruptcy-court protection within about a week as the specialty retailer of women's apparel, jewelry and accessories grapples with higher debt and declining sales, the Wall Street Journal reported Monday, citing people familiar with the matter.

Sandpoint, Idaho-based Coldwater Creek made attempts to avoid a bankruptcy filing by refinancing debt or selling itself to a private equity firm, but was reportedly unsuccessful in those attempts. The company had said in mid-October 2013 that its board of directors authorized the evaluation of strategic alternatives to enhance value for stockholders.

In December 2013, Coldwater Creek reported a net loss for the third quarter that widened to $23.79 million or $0.78 per share from $20.53 million or $0.67 per share in the year-ago period. Net sales for the quarter declined 18 percent to $154.49 million from $188.12 million in the prior-year period.

Coldwater Creek had total liabilities of $353.10 million as well as cash and cash equivalents of $6.79 million as at November 2, 2013. The company ended the third quarter with 343 premium retail stores, 36 factory stores, and 7 spas.

CWTR closed Monday's trading at $0.16, down $0.51 or 76.12 percent on a volume of 8.55 million shares.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Almost 71 percent of Americans say they don't save enough for their retirement, while around 54 percent believe they will never pay off their debt fully, according to a new national survey. The latest survey, commissioned by Experian together with Get Rich Slowly and other top U.S. personal finance... The biotech space is not for the faint hearted, given the ebbs and flows in terms of the returns from investing in it. However, for one who perseveres and astutely devises strategies with full cognizance of key regulatory events coming up, the probability of drug candidates getting FDA's blessings and sympathy plays in the space, it provides a sea of opportunity and huge upside prospects. Alcobra Ltd.'s Investigational New Drug Applications for drug candidate MDX in Attention Deficit Hyperactivity Disorder and Fragile X Syndrome have been put on full clinical hold, following adverse neurological findings in a pre-clinical study.
comments powered by Disqus
Follow RTT